Endoscopic Management of Weight Recurrence Following Bariatric Surgery

Front Endocrinol (Lausanne). 2022 Jul 14:13:946870. doi: 10.3389/fendo.2022.946870. eCollection 2022.

Abstract

Metabolic and bariatric surgery is the most effective therapy for weight loss and improving obesity-related comorbidities, comprising the Roux-en-Y gastric bypass (RYGB), gastric banding, sleeve gastrectomy (SG), and biliopancreatic diversion with duodenal switch. While the effectiveness of weight loss surgery is well-rooted in existing literature, weight recurrence (WR) following bariatric surgery is a concern. Endoscopic bariatric therapy presents an anatomy-preserving and minimally invasive option for managing WR in select cases. In this review article, we will highlight the endoscopic management techniques for WR for the most commonly performed bariatric surgeries in the United States -RYGB and SG. For each endoscopic technique, we will review weight loss outcomes in the short and mid-terms and discuss safety and known adverse events. While there are multiple endoscopic options to help address anatomical issues, patients should be managed in a multidisciplinary approach to address anatomical, nutritional, psychological, and social factors contributing to WR.

Keywords: Roux-En-Y gastric bypass; endoscopic sleeve gastroplasty; metabolic and bariatric surgery; sleeve gastrectomy; transoral outlet reduction; weight recurrence.

Publication types

  • Review

MeSH terms

  • Bariatric Surgery* / adverse effects
  • Gastrectomy / adverse effects
  • Gastrectomy / methods
  • Gastric Bypass* / methods
  • Humans
  • Retrospective Studies
  • United States
  • Weight Loss